197 related articles for article (PubMed ID: 22977476)
1. Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer.
Toiyama Y; Miki C; Inoue Y; Tanaka K; Mohri Y; Kusunoki M
Exp Ther Med; 2011 Jan; 2(1):95-101. PubMed ID: 22977476
[TBL] [Abstract][Full Text] [Related]
2. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer.
Ishizuka M; Nagata H; Takagi K; Kubota K
Ann Surg; 2009 Aug; 250(2):268-72. PubMed ID: 19638907
[TBL] [Abstract][Full Text] [Related]
3. Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer.
Ishizuka M; Nagata H; Takagi K; Horie T; Kubota K
Ann Surg; 2007 Dec; 246(6):1047-51. PubMed ID: 18043109
[TBL] [Abstract][Full Text] [Related]
4. Changes in modified Glasgow prognostic score after neoadjuvant chemotherapy is a prognostic factor in clinical stage II/III esophageal cancer.
Otowa Y; Nakamura T; Takiguchi G; Tomono A; Yamamoto M; Kanaji S; Imanishi T; Suzuki S; Tanaka K; Itoh T; Kakeji Y
Dis Esophagus; 2016; 29(2):146-51. PubMed ID: 25515972
[TBL] [Abstract][Full Text] [Related]
5. Glasgow Prognostic Score (GPS) can be a useful indicator to determine prognosis of patients with colorectal carcinoma.
Nozoe T; Matono R; Ijichi H; Ohga T; Ezaki T
Int Surg; 2014; 99(5):512-7. PubMed ID: 25216413
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.
Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695
[TBL] [Abstract][Full Text] [Related]
7. Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer.
Jiang X; Hiki N; Nunobe S; Kumagai K; Kubota T; Aikou S; Sano T; Yamaguchi T
Br J Cancer; 2012 Jul; 107(2):275-9. PubMed ID: 22713657
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancer.
Hirashima K; Watanabe M; Shigaki H; Imamura Y; Ida S; Iwatsuki M; Ishimoto T; Iwagami S; Baba Y; Baba H
J Gastroenterol; 2014 Jun; 49(6):1040-6. PubMed ID: 23821018
[TBL] [Abstract][Full Text] [Related]
9. Glasgow prognostic score is a better predictor of the long-term survival in patients with gastric cancer, compared to the modified Glasgow prognostic score or high-sensitivity modified Glasgow prognostic score.
Hirahara N; Matsubara T; Kaji S; Kawabata Y; Hyakudomi R; Yamamoto T; Uchida Y; Ishitobi K; Takai K; Tajima Y
Oncotarget; 2020 Nov; 11(45):4169-4177. PubMed ID: 33227100
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of Glasgow prognostic score in patients with stage II colorectal cancer.
Lin MS; Huang JX; Yu H
Int J Clin Exp Med; 2015; 8(10):19138-43. PubMed ID: 26770545
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of an inflammation-based prognostic score (mGPS) for predicting survival in patients with unresectable malignant biliary obstruction.
Iwasaki Y; Ishizuka M; Kato M; Kita J; Shimoda M; Kubota K
World J Surg; 2013 Sep; 37(9):2222-8. PubMed ID: 23657751
[TBL] [Abstract][Full Text] [Related]
12. Inflammation-based prognostic score predicts biliary stent patency in patients with unresectable malignant biliary obstruction.
Iwasaki Y; Ishizuka M; Kato M; Kita J; Shimoda M; Kubota K
Anticancer Res; 2014 Jul; 34(7):3617-22. PubMed ID: 24982377
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
[TBL] [Abstract][Full Text] [Related]
14. [Predictive and Prognostic significance of high-sensitivity modified Glasgow Prognostic Score (HS-mGPS) in advanced gastric cancer patients treated with neoadjuvant chemotherapy].
Cui Y; Li J; Cao YH; Liu MY; Shi ZX; Gao TH
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):195-200. PubMed ID: 28316218
[No Abstract] [Full Text] [Related]
15. Preoperative change of modified Glasgow prognostic score after stenting predicts the long-term outcomes of obstructive colorectal cancer.
Sato R; Oikawa M; Kakita T; Okada T; Abe T; Yazawa T; Tsuchiya H; Akazawa N; Sato M; Ohira T; Harada Y; Okano H; Ito K; Ohuchi N; Tsuchiya T
Surg Today; 2020 Mar; 50(3):232-239. PubMed ID: 31407166
[TBL] [Abstract][Full Text] [Related]
16. Colorectal Cancer, Systemic Inflammation, and Outcome: Staging the Tumor and Staging the Host.
Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
Ann Surg; 2016 Feb; 263(2):326-36. PubMed ID: 25575264
[TBL] [Abstract][Full Text] [Related]
17. Association between preoperative C-reactive protein level and colorectal cancer survival: a meta-analysis.
Woo HD; Kim K; Kim J
Cancer Causes Control; 2015 Nov; 26(11):1661-70. PubMed ID: 26376895
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the Glasgow prognostic score in colorectal cancer: a meta-analysis of 9,839 patients.
Lu X; Guo W; Xu W; Zhang X; Shi Z; Zheng L; Zhao W
Cancer Manag Res; 2019; 11():229-249. PubMed ID: 30636896
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of the Glasgow Prognostic Score or Modified Glasgow Prognostic Score for Patients with Colorectal Cancer Receiving Various Treatments: a Systematic Review and Meta-Analysis.
He L; Li H; Cai J; Chen L; Yao J; Zhang Y; Xu W; Geng L; Yang M; Chen P; Zheng J; Yang Y; Gong S
Cell Physiol Biochem; 2018; 51(3):1237-1249. PubMed ID: 30481755
[TBL] [Abstract][Full Text] [Related]
20. Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer.
Moyes LH; Leitch EF; McKee RF; Anderson JH; Horgan PG; McMillan DC
Br J Cancer; 2009 Apr; 100(8):1236-9. PubMed ID: 19319134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
